Betta Pushes Icotinib For China National Reimbursement List
This article was originally published in PharmAsia News
Executive Summary
Icotinib, developed by Zhejiang Betta Pharmaceutical, is hailed as a success of China’s National Major New Drug Program, having obtained support from national and local governments during its research and development program.